Table 1 Baseline patients’ characteristics
Characteristic | Total number of patients (N = 36) |
|---|---|
Age, years | |
Median | 66 |
Range | 25–83 |
Sex, n (%) | |
Female | 32 (88.9) |
Male | 4 (11.1) |
Time since del5q diagnosis (months) | |
Median | 10 |
Range | 1–83 |
IPSS risk score, n (%) | |
0 | 14 (38.9) |
0.5 | 22 (61.1) |
Number of previous treatment lines | |
0 | 18 |
1 | 6 |
2 | 8 |
3 | 4 |
Transfusion dependency (months) | |
Median | 10 |
Range | 2–47 |
RBC transfusion units/8 weeks | |
Median | 2 |
Range | 1–10 |
Absolute neutrophil count (ANC), x 109/l | |
Median | 1.6 |
Range | 0.4–5.2 |
Baseline hemoglobin level, g/dl | |
Median | 7.4 |
Range | 5.2–8 |
Baseline platelet count, x 109/l | |
Median | 259 |
Range | 102–742 |
Myelogram | |
High cellularity | 30 |
Low cellularity | 6 |
Bone marrow dysplasia | |
1 line | 8 |
2 lines | 16 |
3 lines | 12 |
Lactate dehydrogenase (LDH) level, n (%) | |
Normal | 13 (36.1) |
Increased | 23 (63.9) |
Ferritin level | |
Elevated | 26 |
Missing | 10 |